Related Experiment Videos
[Dermatological diseases influenced by pregnancy]
1Service de dermatologie, hôpital Fournier, 36, quai de la Bataille, 54035 Nancy. jl.schmutz@chu-nancy.fr
Summary
Pregnancy can trigger or worsen autoimmune diseases like lupus, impacting maternal and fetal health. Close medical surveillance is crucial for pregnant women with connective tissue diseases.
Area of Science:
- Rheumatology
- Obstetrics
- Dermatology
Context:
- Pregnancy significantly impacts several autoimmune and connective tissue diseases.
- Systemic lupus erythematosus (SLE) flares occur in 60% of pregnancies, with renal damage and hypertension being key prognostic factors.
- Neonatal lupus risk is linked to anti-Ro-SSA and anti-La-SSB antibodies, posing an unpredictable threat.
Purpose:
- To review the influence of pregnancy on various autoimmune and connective tissue disorders.
- To highlight potential risks and management strategies for pregnant patients with these conditions.
- To emphasize the necessity of multidisciplinary surveillance for lupus patients planning pregnancy.
Summary:
- Systemic lupus erythematosus (SLE) flares are common during pregnancy, affecting 60% of cases and posing risks like prematurity and neonatal lupus.
- Other connective tissue disorders such as scleroderma and dermatopolymyositis may be exacerbated by pregnancy, particularly with renal involvement.
- Bullous diseases like porphyria and pemphigus can appear or worsen during pregnancy, while sarcoidosis has a negligible impact.
- Various genetic conditions including Ehlers-Danlos syndrome and neurofibromatosis can lead to complications during pregnancy.
- Genital infections and varicella pose significant risks to both mother and infant during pregnancy.
Impact:
- Highlights the critical need for specialized, multidisciplinary care for pregnant women with autoimmune diseases.
- Informs clinical practice regarding risk assessment and management of pregnancy in patients with connective tissue and bullous disorders.
- Underscores the importance of monitoring for fetal complications such as prematurity and neonatal lupus.